1. Strategy for starting BoNT treatment (written consent, initial dose and subsequent doses, interval, follow-up)
- Author
-
Joseph K.C. Tsui
- Subjects
0106 biological sciences ,medicine.medical_specialty ,Botulinum Toxins ,Initial dose ,Symptomatic treatment ,MEDLINE ,Toxicology ,01 natural sciences ,Injections ,03 medical and health sciences ,Informed consent ,Medicine ,Humans ,In patient ,Cervical dystonia ,Intensive care medicine ,Torticollis ,0303 health sciences ,Informed Consent ,business.industry ,010604 marine biology & hydrobiology ,030302 biochemistry & molecular biology ,medicine.disease ,Botulinum toxin ,Treatment Outcome ,Strategic approach ,business ,medicine.drug ,Follow-Up Studies - Abstract
Botulinum toxin (BoNT) has become a therapeutic agent for a large variety of medical conditions. It is a symptomatic treatment and in most cases requires repeat injections at regular intervals. The first session is crucial in establishing rapport between the physician and the patient to ensure a continuity of treatment on a long term basis. Since the clinical practice varies widely across different therapeutic indications and in different clinical settings around the world, a general set of strategic approach is difficult to be formulated. This article will focus on the important issues when starting BoNT treatment in patients with cervical dystonia (CD).
- Published
- 2019